NO20052991L - Kinazolinforbindelser. - Google Patents
Kinazolinforbindelser.Info
- Publication number
- NO20052991L NO20052991L NO20052991A NO20052991A NO20052991L NO 20052991 L NO20052991 L NO 20052991L NO 20052991 A NO20052991 A NO 20052991A NO 20052991 A NO20052991 A NO 20052991A NO 20052991 L NO20052991 L NO 20052991L
- Authority
- NO
- Norway
- Prior art keywords
- quinazoline
- therapy
- formula
- preparation
- methods
- Prior art date
Links
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 title 1
- 238000002360 preparation method Methods 0.000 abstract 2
- 125000006163 5-membered heteroaryl group Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02293239 | 2002-12-24 | ||
| PCT/GB2003/005636 WO2004058752A1 (en) | 2002-12-24 | 2003-12-22 | Quinazoline compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052991D0 NO20052991D0 (no) | 2005-06-17 |
| NO20052991L true NO20052991L (no) | 2005-07-19 |
Family
ID=32668916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052991A NO20052991L (no) | 2002-12-24 | 2005-06-17 | Kinazolinforbindelser. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7407946B2 (ko) |
| EP (1) | EP1575946A1 (ko) |
| JP (1) | JP2006516138A (ko) |
| KR (1) | KR20050087863A (ko) |
| CN (1) | CN1753889A (ko) |
| AU (1) | AU2003290322A1 (ko) |
| BR (1) | BR0317680A (ko) |
| CA (1) | CA2508921A1 (ko) |
| MX (1) | MXPA05006920A (ko) |
| NO (1) | NO20052991L (ko) |
| WO (1) | WO2004058752A1 (ko) |
| ZA (1) | ZA200504828B (ko) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0317717B8 (pt) * | 2002-12-24 | 2021-05-25 | Astrazeneca Ab | composto, composição farmacêutica, e uso de um composto |
| BRPI0409427A (pt) * | 2003-04-16 | 2006-04-18 | Astrazeneca Ab | composto, uso do mesmo, composição farmacêutica, método de tratamento de um humano sofrendo de uma doença hiperproliferativa, e, processo para a preparação de um composto ou de um sal, éster ou pró-droga farmaceuticamente aceitáveis do mesmo |
| ATE401080T1 (de) * | 2003-06-02 | 2008-08-15 | Astrazeneca Ab | (3-((chinazolin-4-yl)amino)-1h-pyrazol-1- yl)acetamid derivate und verwandte verbindungen als aurora kinase inhibitoren zur behandlung von proliferativen erkrankungen wie krebs |
| AU2005293336B2 (en) | 2004-10-12 | 2009-05-28 | Astrazeneca Ab | Quinazoline derivatives |
| WO2006044687A2 (en) | 2004-10-15 | 2006-04-27 | Takeda San Diego, Inc. | Kinase inhibitors |
| US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| EP1785420A1 (en) * | 2005-11-14 | 2007-05-16 | 4Sc Ag | Thiazole analogues and uses thereof |
| EP1994028A1 (en) * | 2006-03-02 | 2008-11-26 | AstraZeneca AB | Quinoline derivatives for treating cancer |
| UY30183A1 (es) | 2006-03-02 | 2007-10-31 | Astrazeneca Ab | Derivados de quinolina |
| EP1994024A2 (en) * | 2006-03-02 | 2008-11-26 | AstraZeneca AB | Quinoline derivatives |
| WO2007113548A1 (en) * | 2006-04-06 | 2007-10-11 | Astrazeneca Ab | Naphthyridine derivatives |
| US20070258976A1 (en) * | 2006-05-04 | 2007-11-08 | Ward Keith W | Combination Therapy for Diseases Involving Angiogenesis |
| GB0609617D0 (en) | 2006-05-16 | 2006-06-21 | Astrazeneca Ab | Process & intermediate |
| US20100120717A1 (en) | 2006-10-09 | 2010-05-13 | Brown Jason W | Kinase inhibitors |
| EP2149565A1 (de) | 2008-07-24 | 2010-02-03 | Bayer Schering Pharma AG | Sulfonsubstituierte Chinazolinderivate als Immunmodulatoren zur Behandlung von enzündlichen und allergischen Erkrankungen |
| CN102971313A (zh) | 2010-04-14 | 2013-03-13 | 百时美施贵宝公司 | 新颖的葡糖激酶激活剂及其使用方法 |
| PL2666016T3 (pl) * | 2011-01-21 | 2017-07-31 | Basilea Pharmaceutica Ag | Zastosowanie BUBR1 jako biomarkera odpowiedzi lekowej |
| AU2014216178B2 (en) | 2013-02-15 | 2018-06-28 | KALA BIO, Inc. | Therapeutic compounds and uses thereof |
| US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
| CN105189462B (zh) | 2013-02-20 | 2017-11-10 | 卡拉制药公司 | 治疗性化合物和其用途 |
| US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
| KR20160099084A (ko) | 2013-11-01 | 2016-08-19 | 칼라 파마슈티컬스, 인크. | 치료 화합물의 결정질 형태 및 그의 용도 |
| MX2019002629A (es) | 2016-09-08 | 2019-10-07 | Kala Pharmaceuticals Inc | Formas cristalinas de compuestos terapéuticos y usos de los mismos. |
| CA3036340A1 (en) | 2016-09-08 | 2018-03-15 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
| CA3036336A1 (en) | 2016-09-08 | 2018-03-15 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK3822002A3 (en) | 1999-09-21 | 2002-10-08 | Astrazeneca Ab | Quinazoline derivatives, process for the preparation thereof and their use |
| GB9922171D0 (en) | 1999-09-21 | 1999-11-17 | Zeneca Ltd | Chemical compounds |
| CZ20024120A3 (cs) * | 2000-06-28 | 2003-03-12 | Astrazeneca Ab | Substituované chinazolinové deriváty a jejich použití jako inhibitory |
| US7132427B2 (en) * | 2001-06-21 | 2006-11-07 | Ariad Pharmaceuticals, Inc. | Quinazolines and uses thereof |
| BRPI0317717B8 (pt) * | 2002-12-24 | 2021-05-25 | Astrazeneca Ab | composto, composição farmacêutica, e uso de um composto |
| WO2004058782A1 (en) * | 2002-12-24 | 2004-07-15 | Astrazeneca Ab | Therapeutic quinazoline derivatives |
-
2003
- 2003-12-22 EP EP03782681A patent/EP1575946A1/en not_active Withdrawn
- 2003-12-22 CA CA002508921A patent/CA2508921A1/en not_active Abandoned
- 2003-12-22 WO PCT/GB2003/005636 patent/WO2004058752A1/en active Application Filing
- 2003-12-22 AU AU2003290322A patent/AU2003290322A1/en not_active Abandoned
- 2003-12-22 JP JP2004563353A patent/JP2006516138A/ja active Pending
- 2003-12-22 MX MXPA05006920A patent/MXPA05006920A/es not_active Application Discontinuation
- 2003-12-22 BR BR0317680-0A patent/BR0317680A/pt not_active Application Discontinuation
- 2003-12-22 KR KR1020057012019A patent/KR20050087863A/ko not_active Application Discontinuation
- 2003-12-22 US US10/539,481 patent/US7407946B2/en not_active Expired - Fee Related
- 2003-12-22 CN CNA2003801098990A patent/CN1753889A/zh active Pending
-
2005
- 2005-06-13 ZA ZA200504828A patent/ZA200504828B/en unknown
- 2005-06-17 NO NO20052991A patent/NO20052991L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004058752A1 (en) | 2004-07-15 |
| US7407946B2 (en) | 2008-08-05 |
| CA2508921A1 (en) | 2004-07-15 |
| KR20050087863A (ko) | 2005-08-31 |
| BR0317680A (pt) | 2005-11-29 |
| MXPA05006920A (es) | 2006-02-10 |
| CN1753889A (zh) | 2006-03-29 |
| JP2006516138A (ja) | 2006-06-22 |
| US20060058523A1 (en) | 2006-03-16 |
| NO20052991D0 (no) | 2005-06-17 |
| AU2003290322A1 (en) | 2004-07-22 |
| ZA200504828B (en) | 2008-02-27 |
| EP1575946A1 (en) | 2005-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052991L (no) | Kinazolinforbindelser. | |
| NO20052855L (no) | Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav. | |
| ATE412657T1 (de) | Therapeutische quinazolin-derivate | |
| NO20051695L (no) | Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer | |
| AU2910600A (en) | Phenyl urea and phenyl thiourea derivatives | |
| NO20060972L (no) | Pyridylderivater og deres anvendelse som terapeutiske midler | |
| HUP0400246A2 (hu) | 1,2,4-Trioxolánt tartalmazó maláriaellenes gyógyszerkészítmények és eljárás az előállításukra és az alkalmazásukra | |
| NO20060665L (no) | N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer | |
| NO20085217L (no) | Effektive pyrimidinderivater i behandlingen av kreft | |
| NO20053890L (no) | Syntese av 4-amino-2-butenolklorider og anvendelse derav for fremstilling av 3-cyanokinoliner | |
| NO20061157L (no) | 4-pyramidonderivater og deres anvendelse som peptidylpeptidmeinbibitorer | |
| NO20082101L (no) | Pyrido-, pyrazo- og pyrimido-pyrimidinderivater som mTor inhibitorer | |
| MXPA05013349A (es) | Derivados de 2-amino-pirimidina como inhibidores de quinasa raf. | |
| BR0207863A (pt) | Inibidores piridìnicos de metaloproteinases da matriz | |
| NO20060973L (no) | Pyridylderivater og deres anvendelse som tempeutiske midler | |
| NO20062474L (no) | Antivirale midler bestaende av diazaindol-dikarbonyl-piperazinyl | |
| BRPI0413467A (pt) | aminopironas e seu uso como inibidoras da atm | |
| NO20060147L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| DK0751930T3 (da) | Amidinoderivater anvendelige som nitrogenoxid-synthase-inhibitorer | |
| NO20070570L (no) | Forbindelser. | |
| DE60121461D1 (de) | Kondensierte pyridoindolderivate | |
| NO20044526L (no) | Hemisterlinderivater og anvendelser derav | |
| DE69916066D1 (de) | Neue benzoxazole mit pde-hemmender wirkung | |
| GB0308201D0 (en) | Novel compounds | |
| NO20072310L (no) | 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamidderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |